Elevated expression of FGF7 protein is common in human gastric diseases

被引:29
作者
Shaoul, Ron
Eliahu, Liat
Sher, Ifat
Hamlet, Yaheli
Miselevich, Ines
Goldshmidt, Orit
Ron, Dina [1 ]
机构
[1] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel
[2] Bnai Zion Med Ctr, Dept Pathol, Haifa, Israel
[3] Technion Israel Inst Technol, Dept Pediat, Bnai Zion Med Ctr, Fac Med, Haifa, Israel
基金
以色列科学基金会;
关键词
anti-sense RNA; fibroblast growth factor; FGF7; Helicobacter pylori; gastric diseases;
D O I
10.1016/j.bbrc.2006.08.198
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growth alterations within the gastric mucosa during chronic gastric inflammation are key steps in gastric cancer development. FGF7, a specific mitogen for epithelial cells, is implicated in epithelial tissue repair and cancer. We investigated FGF7 expression in normal human stomach, and in 35 cases from various gastric pathologies including 23 gastritis and 8 adenocarcinoma cases. Modest FGF7 protein levels were detected in the normal mucosal gland epithelium and in stromal fibroblasts. FGF7 protein levels, however, were markedly increased in the mucosal epithelium of all gastric inflammation cases. A similar elevated expression was also observed in gastric adenocarcinoma. Upregulation of FGF7 protein was associated with a modest increase in FGF7 mRNA expression. Interestingly, high levels of FGF7 anti-sense (AS) RNA were observed in the gastric pathologies, at the same sites where FGF7 protein was upregulated. Altogether, these findings suggest a role for FGF7 in maintaining gastric mucosa integrity, and that FGF7 protein levels are regulated mainly by posttranscriptional mechanisms. The elevated FGF7 protein levels in gastric inflammation and gastric cancer, together with the known oncogenic potential of FGF7, implicate excessive FGF7 signaling in gastric tumorigenesis, and point to FGF7 as an attractive target for gastric cancer prevention and treatment. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:825 / 833
页数:9
相关论文
共 44 条
[1]   Perlecan is essential for cartilage and cephalic development [J].
Arikawa-Hirasawa, E ;
Watanabe, H ;
Takami, H ;
Hassell, JR ;
Yamada, Y .
NATURE GENETICS, 1999, 23 (03) :354-358
[2]   Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene [J].
Arikawa-Hirasawa, E ;
Wilcox, WR ;
Le, AH ;
Silverman, N ;
Govindraj, P ;
Hassell, JR ;
Yamada, Y .
NATURE GENETICS, 2001, 27 (04) :431-434
[3]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[4]   Role of receptor tyrosine kinases in gastric cancer:: New targets for a selective therapy [J].
Becker, J. C. ;
Mueller-Tidow, C. ;
Serve, H. ;
Domschke, W. ;
Pohle, T. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (21) :3297-3305
[5]  
BRAUCHLE M, 1994, ONCOGENE, V9, P3199
[6]  
Brauchle M, 1996, AM J PATHOL, V149, P521
[7]   Functional characterization of the keratinocyte growth factor system in human fetal gastrointestinal tract [J].
Chailler, P ;
Basque, JR ;
Corriveau, L ;
Ménard, D .
PEDIATRIC RESEARCH, 2000, 48 (04) :504-510
[8]  
CHEDID M, 1994, J BIOL CHEM, V269, P10753
[9]   THE FGF6 GENE WITHIN THE FGF MULTIGENE FAMILY [J].
COULIER, F ;
OLLENDORFF, V ;
MARICS, I ;
ROSNET, O ;
BATOZ, M ;
PLANCHE, J ;
MARCHETTO, S ;
PEBUSQUE, MJ ;
DELAPEYRIERE, O ;
BIRNBAUM, D .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 638 :53-61
[10]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867